J Pathol. 1992 Jan;166(1):7-12.

The epidermal growth factor receptor in human pancreatic cancer.

Lemoine NR, Hughes CM, Barton CM, Poulsom R, Jeffery RE, Klöppel G, Hall PA, Gullick WJ.

Source

Molecular Pathology Laboratory, Hammersmith Hospital, London, U.K.

Abstract

The epidermal growth factor receptor (EGFR) and its ligands are thought to be important in the control of proliferation of many epithelial systems, including the exocrine pancreas. Abnormalities in expression of two of the known ligands of the EGFR, transforming growth factor alpha and epidermal growth factor, occur frequently in ductal adenocarcinoma of the human pancreas. We have examined an archival series of cases of pancreatic pathology for expression of the EGFR using the anti-EGFR antiserum 12E and found that there is almost ubiquitous overexpression of EGFR in pancreatic cancer and in chronic pancreatitis. Southern blot analysis showed no evidence of amplification or rearrangement of the EGFR gene. We conclude that an autocrine loop involving the EGFR system may be involved in the genesis of both neoplasia and reactive hyperplasia of pancreatic ductal epithelium.

PMID:: 1538276; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Medical

Pancreatic Cancer - MedlinePlus Health Information

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. [J Pathol. 1991]
Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer.
Barton CM, Hall PA, Hughes CM, Gullick WJ, Lemoine NR. J Pathol. 1991 Feb; 163(2):111-6.
Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma. [Gut. 2002]
Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma.
Yeh TS, Jan YY, Chiu CT, Ho YB, Chen TC, Lee KF, Chan KM, Hsu JC, Hwang TL, Chen MF. Gut. 2002 Nov; 51(5):712-6.
The erbB-3 gene in human pancreatic cancer. [J Pathol. 1992]
The erbB-3 gene in human pancreatic cancer.
Lemoine NR, Lobresco M, Leung H, Barton C, Hughes CM, Prigent SA, Gullick WJ, Klöppel G. J Pathol. 1992 Nov; 168(3):269-73.
Review Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications. [Clin Cancer Res. 1998]
Review Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications.
Ciardiello F, Tortora G. Clin Cancer Res. 1998 Apr; 4(4):821-8.
Review Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate. [World J Urol. 1995]
Review Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate.
Sherwood ER, Lee C. World J Urol. 1995; 13(5):290-6.

See reviews... See all...

Cited by 23 PubMed Central articles

Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma. [Am J Surg. 2010]
Epidermal growth factor receptor (EGFR) intron 1 polymorphism and clinical outcome in pancreatic adenocarcinoma.
Frolov A, Liles JS, Kossenkov AV, Tzeng CW, Jhala N, Kulesza P, Varadarajulu S, Eloubeidi M, Heslin MJ, Arnoletti JP. Am J Surg. 2010 Sep; 200(3):398-405. Epub 2010 Apr 21.
Review Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer. [World J Gastroenterol. 2010]
Review Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer.
Bayraktar S, Bayraktar UD, Rocha-Lima CM. World J Gastroenterol. 2010 Feb 14; 16(6):673-82.
Small molecule tyrosine kinase inhibitors in pancreatic cancer. [Biologics. 2008]
Small molecule tyrosine kinase inhibitors in pancreatic cancer.
Gupta S, El-Rayes BF. Biologics. 2008 Dec; 2(4):707-15.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The epidermal growth factor receptor in human pancreatic cancer.
The epidermal growth factor receptor in human pancreatic cancer.
J Pathol. 1992 Jan ;166(1):7-12.

PubMed
Anatomy of the nipple and breast ducts revisited.
Anatomy of the nipple and breast ducts revisited.
Cancer. 2004 Nov 1 ;101(9):1947-57.

PubMed
Association of increased basement membrane invasiveness with absence of estrogen...
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
J Cell Physiol. 1992 Mar ;150(3):534-44.

PubMed
Association of hormone replacement therapy to estrogen and progesterone receptor...
Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
Cancer. 2004 Oct 1 ;101(7):1490-500.

PubMed
Combined effects of body size, parity, and menstrual events on breast cancer inc...
Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries.
Am J Epidemiol. 1992 Jan 15 ;135(2):153-68.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: